Oleate induces a myofibroblast-like phenotype in mesangial cells

被引:19
作者
Mishra, Rangnath [1 ,2 ]
Simonson, Michael S. [1 ,2 ]
机构
[1] Case Western Reserve Univ, Div Nephrol, Dept Med, Div Nephrol & Hypertens, Cleveland, OH 44106 USA
[2] Univ Hosp Case Med Ctr, Cleveland, OH USA
关键词
mesangial cells; microvascular; pericytes; free fatty acids; TGF-beta; fibrosis;
D O I
10.1161/ATVBAHA.107.157339
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-High circulating free fatty acids, commonly associated with obesity and insulin resistance, impair structure and function of the microvasculature. However, the mechanisms by which fatty acids cause microvascular remodeling are unclear. Using the mesangial cell model of microvascular pericytes, we demonstrate that the monounsaturated free fatty acid oleate induces a myofibroblast phenotype, an important cell fate transition in fibrotic remodeling of the extracellular matrix. Materials and Results-Oleate induced a time- and dose-dependent increase in secretion of collagen I and fibronectin. Oleate also induced the myofibroblast phenotype markers alpha smooth muscle actin and ED-A fibronectin, and the magnitude of marker protein expression was similar to that for transforming growth factor (TGF)-beta. Oleate raised TGF-beta secretion 2.2-fold, and processing of latent to bioactive TGF-beta was also elevated. Oleate rapidly stimulated extracellular signal-regulated kinase1/2, and a pharmacological MEK inhibitor blocked TGF-beta secretion and conversion to the myofibroblast phenotype. A neutralizing TGF-beta antibody and a TGF-beta receptor kinase inhibitor blocked oleate-induced collagen I, alpha smooth muscle actin, and ED- A fibronectin, suggesting that oleate-stimulated TGF-beta was necessary for inducing myofibroblasts. Conclusions-Collectively, these results demonstrate that oleate can induce a myofibroblast phenotype in mesangial cells, which suggests a mechanism whereby elevated free fatty acids might promote microvascular remodeling in vivo.
引用
收藏
页码:541 / 547
页数:7
相关论文
共 56 条
[1]   AN ASSAY FOR TRANSFORMING GROWTH-FACTOR-BETA USING CELLS TRANSFECTED WITH A PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTER LUCIFERASE CONSTRUCT [J].
ABE, M ;
HARPEL, JG ;
METZ, CN ;
NUNES, I ;
LOSKUTOFF, DJ ;
RIFKIN, DB .
ANALYTICAL BIOCHEMISTRY, 1994, 216 (02) :276-284
[2]  
Abrass CK, 2006, CONTRIB NEPHROL, V151, P106, DOI 10.1159/000095323
[3]   Making sense of latent TGFβ activation [J].
Annes, JP ;
Munger, JS ;
Rifkin, DB .
JOURNAL OF CELL SCIENCE, 2003, 116 (02) :217-224
[4]   Endothelial/pericyte interactions [J].
Armulik, A ;
Abramsson, A ;
Betsholtz, C .
CIRCULATION RESEARCH, 2005, 97 (06) :512-523
[5]   Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities [J].
Bjarnegård, M ;
Enge, M ;
Norlin, J ;
Gustafsdottir, S ;
Fredriksson, S ;
Abramsson, A ;
Takemoto, M ;
Gustafsson, E ;
Fässler, R ;
Betsholtz, C .
DEVELOPMENT, 2004, 131 (08) :1847-1857
[6]   Free fatty acids in obesity and type 2 diabetes:: defining their role in the development of insulin resistance and β-cell dysfunction [J].
Boden, G ;
Shulman, GI .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 :14-23
[7]   Molecular mediators of hepatic steatosis and liver injury [J].
Browning, JD ;
Horton, JD .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) :147-152
[8]   Receptor tyrosine kinase axl modulates the osteogenic differentiation of pericytes [J].
Collett, G ;
Wood, A ;
Alexander, MY ;
Varnum, BC ;
Boot-Handford, RP ;
Ohanian, V ;
Ohanian, J ;
Fridell, YW ;
Canfield, AE .
CIRCULATION RESEARCH, 2003, 92 (10) :1123-1129
[9]   Hepatocyte growth factor antagonizes the profibrotic action of TGF-β1 in mesangial cells by stabilizing smad transcriptional corepressor TGIF [J].
Dai, CS ;
Liu, YH .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (06) :1402-1412
[10]   Free fatty acid levels modulate microvascular function -: Relevance for obesity-associated insulin resistance, hypertension, and microangiopathy [J].
de Jongh, RT ;
Serné, EH ;
Ijzerman, RG ;
de Vries, G ;
Stehouwer, CDA .
DIABETES, 2004, 53 (11) :2873-2882